Outstanding start of keynote lectures at #SNO2023 with Mariella Filbin presenting data on H3K27M tumors. Publication Nature Genetics with first author Ilon Liu recently awarded with the EANO Youngsters award at #EANO2023. SNO EANO OncoAlert

Happy Holidays from the Brain Tumor Center Team! ⛄️

Exciting advancements in the treatment of #DiffuseMidlineGliomas! Dr. Wright et al.'s recently published research paper reviews the complex features of DMGs as it relates to current & past therapeutic approaches. Read the paper here: ms.spr.ly/6010ioOBp #PediatricOncology

The iPLGGc's latest research paper on pediatric low-grade gliomas has been published, featuring input from Dr. Bandopadhayay on the DFBC team. Explore insights on the most common childhood central nervous system (CNS) tumors here: ms.spr.ly/6019ioOEF

Dr. Susan Chi et al. recently published research on the effect of EZH2 inhibitor tazemetostat on disease stabilization for #PediatricOncology patients whose tumors harbored EZH2 mutations or loss of SMARCB1 or SMARCA4 by immunohistochemistry. Read here: ms.spr.ly/6013ioOGF

Congratulations to the first class of Damon Runyon-St. Jude Research Pediatric Cancer Fellows! These exceptional early-career scientists are working to accelerate progress and develop cures for some of the most difficult-to-treat cancers affecting children: bit.ly/3SHfOte

We are proud to announce April A. Apfelbaum, PhD, Costanza Lo Cascio, PhD (Costanza Lo Cascio), and James J. Morrow, MD, PhD (James Morrow) have been named as part of the Inaugural class of Damon Runyon–St. Jude Pediatric Cancer Research Fellows. Congratulations to April,

Here's the latest research from DFBC researchers Dr. Haas-Kogan and Dr. Liu, investigating the effectiveness of everolimus therapy for treating progressive/recurrent pediatric low-grade glioma (pLGG). Access the full paper here: ms.spr.ly/6012ioOJu

Congratulations to 2 of our awesome postdocs, Costanza Lo Cascio & April Apfelbaum, PhD, who are focusing on brain tumors!🥳🧠Mariella Filbin @Bando_Lab Dana-Farber/Boston Children's

The findings from our team's latest research on H3K27-altered diffuse midline gliomas with MAPK pathway alterations are now published! Read the full paper with contributions from our very own Dr. Baird, Dr. Lidov, Dr. Fehnel, Dr. Alexandrescu and Dr. Yeo: ms.spr.ly/6019ioOKh

Check out the latest issue of Pediatric Neurosurgery, from our own Dr. Lissa Baird and two of her esteemed colleagues, featuring articles on pediatric #BrainTumors. This special edition also includes 2 invited articles & guest editing from our DFBC group! ms.spr.ly/6018ioOPK

This Valentine's Day, let's spread love and raise awareness for children battling brain tumors. 💖 #ChildhoodCancer #BrainTumorAwareness 🎗️

February 15th is International Childhood Cancer Day. Today, as every day, we are thankful for our team members for providing unparalleled care to our pediatric cancer patients Together, we can create a world that is free of cancer. #DFBC #ChildhoodCancerDay #PediatricCancer

Brain tumors are the most common tumors in kids. Today is Childhood Cancer Day, honoring the brave superheroes fighting cancer. Our team stands with these amazing kids, offering the world’s best care and treatment and continuing work towards a cure. @BostonChildrens@DanaFaber 🎗️

Happy International Women's Day to the incredible women dedicating their talents and compassion to pediatric brain tumor research and care! Your commitment is shaping brighter futures for young patients every day. #IWD2024 #WomenInScience

This past Thursday, we came together in celebration of our brain tumor patients who have passed during the past 4 years. A wonderful Remembrance Day was held at DFCI for faculty/staff. Thank you to those that were able to attend. 🎗️